4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
GoodRx Holdings, Inc. (GDRX) operates in the Health Information Services industry and is headquartered in Santa Monica, United States with about 697 employees. Its market capitalization is roughly $991 million. In the fiscal year ended 2025-12-31, GDRX reported $797M in revenue and $30M in net income.
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
Interactive charts & full statements → Open the GDRX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $797M | $792M | $750M | $767M | — |
| Gross Profit | $739M | $744M | $683M | $702M | — |
| Operating Income (EBIT) | $88M | $66M | ($27M) | $2M | — |
| Net Income | $30M | $16M | ($9M) | ($33M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $194M | $195M | $196M | $203M | $203M | — |
| Gross Profit | $174M | $177M | $183M | $190M | $190M | — |
| Operating Income (EBIT) | $14M | $23M | $15M | $27M | $23M | — |
| Net Income | $1M | $5M | $1M | $13M | $11M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.4B | $1.4B | $1.6B | $1.6B | — |
| Total Liabilities | $788M | $663M | $827M | $790M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GDRX viewer.
About TickerBase · Data methodology & sources